Danielle Friedman on a Study of Diabetes Among Childhood Cancer Survivors

From Teddi Mellencamp revealing that she had more melanoma spots removed to Isabella Strahan announcing being cancer-free, here’s what’s happening in the oncology space this week.

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.

I was told that after five years in remission, my cancer would be behind me. However, I was not told what life would be like after that milestone.

Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews

A computer model may help predict which patients with breast cancer are more likely to experience neuropathy from taxane therapies.

I was diagnosed with kidney cancer and pancreatic neuroendocrine tumors two years ago, but I’ve learned a lifetime of lessons since.